查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1838463

FC 和糖工程抗體市場分析及預測（至 2034 年）：類型、產品、服務、技術、應用、最終用戶、流程、功能、安裝類型和模式

FC and Glycoengineered Antibodies Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Functionality, Installation Type, Mode
出版日期: | 出版商: Global Insight Services | 英文 370 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

Fc和糖基工程抗體市場預計將從2024年的367億美元增加至2034年的2,796億美元，複合年成長率約為22.5%。 Fc和糖基工程抗體市場包括透過Fc區修飾和糖基工程增強抗體療效的療法。這些抗體針對癌症、自體免疫疾病和感染疾病，可改善免疫系統的參與度和治療效果。這些疾病的盛行率不斷上升，以及以精準醫療和個人化治療方法為重點的創新所推動的生物技術進步，正在推動市場成長。

在治療應用和精準醫療的推動下，Fc 和糖工程抗體市場預計將顯著成長。單株抗體市場因其在靶向癌細胞方面的特異性和有效性而處於領先地位。糖工程抗體因其增強的免疫反應和降低的免疫抗原性而在這一領域日益受到重視。生物相似藥抗體表現第二好，反映了它們的成本效益和在醫療保健系統中日益成長的接受度。在各個細分市場中，由於癌症發生率的上升和對標靶治療的需求，腫瘤學仍然表現最佳。自體免疫疾病細分市場也正在經歷顯著成長，這得益於創新療法治療複雜免疫疾病的需求。糖工程和 Fc 受體調節技術的進步為新的治療方案鋪平了道路。製藥公司之間的策略聯盟與合作正在推動創新並拓展治療方法領域。預計市場將受益於持續的研發努力，提高抗體療效和患者預後。

市場區隔
類型 Fc修飾抗體、糖基化抗體
產品 單株抗體、多株抗體、生物相似藥
服務 合約研究、契約製造、諮詢
科技 重組DNA技術、融合瘤技術、噬菌體展示技術
目的 腫瘤、自體免疫疾病、感染疾病、心血管疾病、神經系統疾病
最終用戶 製藥公司、生技公司、研究機構、CRO
過程 上游工程、下游工序
功能 治療、診斷和調查
安裝類型 內部、外包
模式 靜脈內、皮下

市場概述

在策略定價和創新產品發布的推動下，FC 和糖工程抗體市場正經歷動態的市佔率波動。大型製藥公司正在利用先進的糖工程技術來提高抗體的治療效果，從而加強其競爭地位。該市場的特點是擁有強大的新產品線，專注於個人化醫療和標靶治療。這種技術創新正在推動競爭格局，各公司透過策略聯盟和收購爭奪主導地位。競爭基準化分析顯示少數主要參與者佔據主導地位，而新興生技公司正快速崛起。監管影響，特別是在北美和歐洲，對於塑造市場動態至關重要，需要嚴格的指導方針來確保安全性和有效性。生物技術的進步和對單株抗體的需求不斷成長正在推動市場成長。然而，挑戰依然存在，例如高昂的開發成本和複雜的監管途徑，需要策略規劃和研發投資。

主要趨勢和促進因素

在生物技術進步和標靶治療需求不斷成長的推動下，FC 和糖工程抗體市場正在經歷強勁成長。主要趨勢包括開發具有更高功效和更低免疫抗原性的新一代抗體。這些技術創新為腫瘤學和自體免疫疾病的更有效治療鋪平了道路。此外，個人化醫療正在推動客製化抗體療法的廣泛應用。這種轉變得到了基因和生物標記研究進展的支持。對精準醫療的日益關注是一個關鍵促進因素，它有望改善患者的治療效果並減少副作用。此外，生物相似藥的興起正在重塑市場格局，它為傳統生物製藥提供了具有成本效益的替代品。對生物相似藥開發的監管支援正在進一步加速市場擴張。新興市場擁有發達的醫療基礎設施和日益普及的先進治療方法，提供了豐富的商機。投資於研發和策略夥伴關係的公司完全有能力利用這些趨勢。

限制與挑戰：

FC 和糖基工程抗體市場目前面臨著許多重大的市場限制和挑戰。其中一個關鍵限制因素是這些先進抗體的生產流程複雜且成本高昂，這可能會阻礙中小企業進入市場。這種複雜性往往會導致更高的生產成本，從而可能限制其可近性和應用。此外，監管障礙也構成了巨大的挑戰。這些生物製藥所需的嚴格核准流程可能會延遲市場准入並增加開發成本。此外，市場還面臨熟悉糖基工程的熟練專業人員短缺的問題，這可能會阻礙研發。智慧財產權問題也構成了重大障礙。專利糾紛可能引發法律糾紛，從而扼殺創新。最後，市場必須面對來自傳統單株抗體的競爭，這些單株抗體已經非常成熟，因此可能會限制糖基工程替代品的市場佔有率。總而言之，這些挑戰決定了市場的成長軌跡。

關鍵人物

Glycotope、Argenx、Xencor、Mabwell、ImmunoGen、MacroGenics、Alector、Zymeworks、Alligator Bioscience、MorphoSys、Sorrento Therapeutics、Genmab、Crescendo Biologics、Harbor BioMed、BioAtla

目錄

第 1 章 FC 與糖工程抗體市場概述

  • 調查目的
  • FC 和糖工程抗體市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章 FC 和糖工程抗體市場展望

  • FC和糖工程抗體市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章 FC 和糖工程抗體市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章 FC和糖工程抗體的市場規模

  • FC 和糖工程抗體的市場規模（以價值計算）
  • FC 和糖工程抗體的市場規模（以數量計算）

7. FC 和糖工程抗體市場（按類型）

  • 市場概況
  • Fc工程抗體
  • 糖工程抗體
  • 其他

8. FC 和糖工程抗體市場（按產品）

  • 市場概況
  • 單株抗體
  • 多株抗體
  • 生物相似藥
  • 其他

9. FC 和糖工程抗體市場（按服務）

  • 市場概況
  • 研究合約
  • 契約製造
  • 諮詢
  • 其他

第 10 章 FC 和糖工程抗體市場（按技術）

  • 市場概況
  • 重組DNA技術
  • 融合瘤技術
  • 噬菌體展示技術
  • 其他

第 11 章 FC 和糖工程抗體市場（依應用）

  • 市場概況
  • 腫瘤學
  • 自體免疫疾病
  • 感染疾病
  • 心血管疾病
  • 神經系統疾病
  • 其他

第 12 章 FC 和糖工程抗體市場（依最終用戶分類）

  • 市場概況
  • 製藥公司
  • 生技公司
  • 研究所
  • CRO
  • 其他

13. FC 和糖工程抗體市場（按製程）

  • 市場概況
  • 上游工程
  • 下游工藝
  • 其他

第 14 章 FC 和糖工程抗體市場（按功能）

  • 市場概況
  • 治療
  • 診斷
  • 用於研究目的
  • 其他

15. FC 和糖工程抗體市場（依安裝類型）

  • 市場概況
  • 內部
  • 外包
  • 其他

16. FC 和糖工程抗體市場（按模式）

  • 市場概況
  • 靜脈注射
  • 皮下注射
  • 其他

第 17 章 FC 和糖工程抗體市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章：公司簡介

  • Glycotope
  • Argenx
  • Xencor
  • Mabwell
  • ImmunoGen
  • MacroGenics
  • Alector
  • Zymeworks
  • Alligator Bioscience
  • MorphoSys
  • Sorrento Therapeutics
  • Genmab
  • Crescendo Biologics
  • Harbour BioMed
  • BioAtla
簡介目錄
Product Code: GIS33866

FC and Glycoengineered Antibodies Market is anticipated to expand from $36.7 billion in 2024 to $279.6 billion by 2034, growing at a CAGR of approximately 22.5%. The FC and Glycoengineered Antibodies Market encompasses therapeutics designed to enhance antibody efficacy through Fc region modifications and glycosylation engineering. These antibodies improve immune system engagement and therapeutic outcomes, targeting cancer, autoimmune diseases, and infectious conditions. Rising prevalence of such diseases and advances in biotechnology fuel market growth, with innovations focusing on precision medicine and personalized treatment approaches.

The FC and Glycoengineered Antibodies Market is poised for substantial growth, propelled by advancements in therapeutic applications and precision medicine. The monoclonal antibodies segment leads in performance, driven by their specificity and efficacy in targeting cancer cells. Within this segment, glycoengineered antibodies are gaining prominence due to enhanced immune response and reduced immunogenicity. Biosimilar antibodies follow as the second-highest performing segment, reflecting cost-effectiveness and increasing acceptance in healthcare systems. Among sub-segments, oncology remains the top-performing area, given the rising prevalence of cancer and demand for targeted therapies. The autoimmune diseases sub-segment is also witnessing significant growth, supported by the need for innovative treatments addressing complex immune disorders. Technological advancements in glycoengineering and Fc receptor modulation are paving the way for novel therapeutic options. Strategic partnerships and collaborations among pharmaceutical companies are fostering innovation and expanding the therapeutic landscape. The market is set to benefit from ongoing research and development efforts, enhancing antibody efficacy and patient outcomes.

Market Segmentation
TypeFc Engineered Antibodies, Glycoengineered Antibodies
ProductMonoclonal Antibodies, Polyclonal Antibodies, Biosimilars
ServicesContract Research, Contract Manufacturing, Consulting
TechnologyRecombinant DNA Technology, Hybridoma Technology, Phage Display Technology
ApplicationOncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, CROs
ProcessUpstream Process, Downstream Process
FunctionalityTherapeutic, Diagnostic, Research
Installation TypeIn-house, Outsourced
ModeIntravenous, Subcutaneous

Market Snapshot:

The FC and Glycoengineered Antibodies Market is witnessing dynamic shifts in market share, driven by strategic pricing and innovative product launches. Leading pharmaceutical companies are leveraging advanced glycoengineering techniques to enhance the therapeutic efficacy of antibodies, resulting in a competitive edge. The market is characterized by a robust pipeline of new products, with a focus on personalized medicine and targeted therapies. This innovation is fostering a competitive landscape, where companies are vying for dominance through strategic collaborations and acquisitions. Competition benchmarking reveals a landscape dominated by a few key players, yet emerging biotech firms are rapidly gaining traction. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics, with stringent guidelines ensuring safety and efficacy. The market is poised for growth, driven by advancements in biotechnology and increasing demand for monoclonal antibodies. However, challenges such as high development costs and complex regulatory pathways persist, necessitating strategic planning and investment in R&D.

Geographical Overview:

The market for FC and glycoengineered antibodies is witnessing notable growth across various regions, each with unique characteristics. North America stands at the forefront, propelled by advanced biotechnology infrastructure and substantial R&D investments. The region's robust healthcare sector further catalyzes market expansion, with the United States playing a pivotal role in driving innovation and development. Europe follows closely, showcasing a strong focus on biopharmaceutical advancements and strategic collaborations. Countries such as Germany and the United Kingdom are emerging as key players, fostering a conducive environment for market growth. The region's commitment to healthcare innovation enhances its market potential. In Asia Pacific, the market is experiencing rapid expansion, fueled by increasing healthcare expenditures and technological advancements. China and Japan are leading the charge, with significant investments in antibody research and development. Latin America and the Middle East & Africa are emerging markets, with growing interest in biopharmaceuticals and antibody technologies.

Key Trends and Drivers:

The FC and Glycoengineered Antibodies Market is experiencing robust growth, driven by advancements in biotechnology and increasing demand for targeted therapeutics. Key trends include the development of next-generation antibodies with enhanced efficacy and reduced immunogenicity. These innovations are paving the way for more effective treatments in oncology and autoimmune diseases. Moreover, personalized medicine is gaining traction, with tailored antibody therapies becoming more prevalent. This shift is supported by advancements in genetic and biomarker research. The growing focus on precision medicine is a significant driver, as it promises improved patient outcomes and reduced side effects. Additionally, the rise of biosimilars is reshaping the market landscape, offering cost-effective alternatives to traditional biologics. Regulatory support for biosimilar development is further accelerating market expansion. Opportunities abound in emerging markets, where healthcare infrastructure is improving, and access to advanced therapies is increasing. Companies investing in R&D and strategic collaborations are well-positioned to capitalize on these trends.

Restraints and Challenges:

The FC and Glycoengineered Antibodies Market is currently navigating several significant restraints and challenges. A primary constraint is the intricate and costly manufacturing processes associated with these advanced antibodies, which can deter smaller companies from entering the market. This complexity often results in higher production costs, which can limit accessibility and adoption. Additionally, regulatory hurdles present a formidable challenge. The rigorous approval processes required for these biopharmaceuticals can delay market entry and increase development costs. Furthermore, the market faces a shortage of skilled professionals adept in glycoengineering, which can impede research and development efforts. Intellectual property issues also pose a significant barrier. Patent disputes can arise, leading to potential legal battles that can stall innovation. Lastly, the market must contend with competition from traditional monoclonal antibodies, which, due to their established presence, can limit the market share of glycoengineered alternatives. These challenges collectively shape the market's growth trajectory.

Key Players:

Glycotope, Argenx, Xencor, Mabwell, ImmunoGen, MacroGenics, Alector, Zymeworks, Alligator Bioscience, MorphoSys, Sorrento Therapeutics, Genmab, Crescendo Biologics, Harbour BioMed, BioAtla

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: FC and Glycoengineered Antibodies Market Overview

  • 1.1 Objectives of the Study
  • 1.2 FC and Glycoengineered Antibodies Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Installation Type
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Installation Type
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: FC and Glycoengineered Antibodies Market Outlook

  • 4.1 FC and Glycoengineered Antibodies Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: FC and Glycoengineered Antibodies Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: FC and Glycoengineered Antibodies Market Size

  • 6.1 FC and Glycoengineered Antibodies Market Size, by Value
  • 6.2 FC and Glycoengineered Antibodies Market Size, by Volume

7: FC and Glycoengineered Antibodies Market, by Type

  • 7.1 Market Overview
  • 7.2 Fc Engineered Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Glycoengineered Antibodies
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: FC and Glycoengineered Antibodies Market, by Product

  • 8.1 Market Overview
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Polyclonal Antibodies
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Biosimilars
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: FC and Glycoengineered Antibodies Market, by Services

  • 9.1 Market Overview
  • 9.2 Contract Research
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Contract Manufacturing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Consulting
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: FC and Glycoengineered Antibodies Market, by Technology

  • 10.1 Market Overview
  • 10.2 Recombinant DNA Technology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Hybridoma Technology
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Phage Display Technology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: FC and Glycoengineered Antibodies Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Autoimmune Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Infectious Diseases
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiovascular Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Neurological Disorders
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: FC and Glycoengineered Antibodies Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 CROs
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: FC and Glycoengineered Antibodies Market, by Process

  • 13.1 Market Overview
  • 13.2 Upstream Process
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Downstream Process
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: FC and Glycoengineered Antibodies Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Therapeutic
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Diagnostic
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Research
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: FC and Glycoengineered Antibodies Market, by Installation Type

  • 15.1 Market Overview
  • 15.2 In-house
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Outsourced
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: FC and Glycoengineered Antibodies Market, by Mode

  • 16.1 Market Overview
  • 16.2 Intravenous
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Subcutaneous
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: FC and Glycoengineered Antibodies Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Functionality
    • 17.2.10 North America Market Size and Forecast, by Installation Type
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Functionality
      • 17.2.9.9 United States Market Size and Forecast, by Installation Type
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Functionality
      • 17.2.10.9 Canada Market Size and Forecast, by Installation Type
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Functionality
    • 17.3.10 Europe Market Size and Forecast, by Installation Type
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Installation Type
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Functionality
      • 17.3.10.9 Germany Market Size and Forecast, by Installation Type
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Functionality
      • 17.3.11.9 France Market Size and Forecast, by Installation Type
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Functionality
      • 17.3.12.9 Spain Market Size and Forecast, by Installation Type
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Functionality
      • 17.3.13.9 Italy Market Size and Forecast, by Installation Type
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.9 Netherlands Market Size and Forecast, by Installation Type
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.9 Sweden Market Size and Forecast, by Installation Type
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.9 Switzerland Market Size and Forecast, by Installation Type
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.9 Denmark Market Size and Forecast, by Installation Type
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Functionality
      • 17.3.18.9 Finland Market Size and Forecast, by Installation Type
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Functionality
      • 17.3.19.9 Russia Market Size and Forecast, by Installation Type
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Installation Type
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Installation Type
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Functionality
      • 17.4.9.9 China Market Size and Forecast, by Installation Type
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Functionality
      • 17.4.10.9 India Market Size and Forecast, by Installation Type
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Functionality
      • 17.4.11.9 Japan Market Size and Forecast, by Installation Type
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.9 South Korea Market Size and Forecast, by Installation Type
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Functionality
      • 17.4.13.9 Australia Market Size and Forecast, by Installation Type
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.9 Singapore Market Size and Forecast, by Installation Type
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.9 Indonesia Market Size and Forecast, by Installation Type
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.9 Taiwan Market Size and Forecast, by Installation Type
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.9 Malaysia Market Size and Forecast, by Installation Type
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Installation Type
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Functionality
    • 17.5.10 Latin America Market Size and Forecast, by Installation Type
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.9 Brazil Market Size and Forecast, by Installation Type
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.9 Mexico Market Size and Forecast, by Installation Type
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.9 Argentina Market Size and Forecast, by Installation Type
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Installation Type
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Installation Type
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Installation Type
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Functionality
      • 17.6.10.9 UAE Market Size and Forecast, by Installation Type
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.9 South Africa Market Size and Forecast, by Installation Type
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Installation Type
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Glycotope
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Argenx
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Xencor
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Mabwell
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 ImmunoGen
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 MacroGenics
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Alector
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Zymeworks
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Alligator Bioscience
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 MorphoSys
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Sorrento Therapeutics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Genmab
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Crescendo Biologics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Harbour BioMed
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 BioAtla
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis